FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
About | Sample | Privacy

Medco buys Polymedica for $1.5B

Tools

Medco Health Solutions hopes that what's good for diabetes patients is also good for its bottom line. The company has agreed to pay $1.5 billion to acquire PolyMedica, the nation's largest supplier of blood-glucose testing supplies and other diabetes-related services.

The two companies already have been working together; Medco fills some 50,000 scrips a week for PolyMedica patients, and Polymedica has offered testing supplies and Medicare Part B management services to some Medco clients. The companies say the deal creates "the nation's most advanced large-scale practice focused on diabetes care."

Medco will pay $53 per share for PolyMedica, which closed Monday at $45.29. Together, the two companies will serve some 3.8 million diabetes patients.

- read the CNN report on the deal

Related Articles:
Diabetes epidemic triggers soaring drug market. Report
Medco reaches settlement with DOJ. Report
Medco to launch e-prescribing study with CMS. Report

More stories about PolyMedica   Diabetes   Buyout   Medco Health Solutions  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 2 + 40?
To combat spam, please solve the math question above.